2020
DOI: 10.1007/s40618-020-01219-3
|View full text |Cite
|
Sign up to set email alerts
|

May an adrenal incidentaloma change its nature?

Abstract: Up to 70% of adrenal masses detected in patients affected by extra-adrenal malignancy are metastatic lesions. Therefore, detection of an adrenal mass in patients with active or previous malignancy requires a careful differential diagnostic work-up. 18 F-Fluorodeoxyglucose-positron emission tomography/computed tomography ( 18 F-FDG-PET/CT) is increasingly used to determine the

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2023
2023
2023
2023

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 53 publications
(67 reference statements)
0
1
0
Order By: Relevance
“…Nonfunctional adrenal incidentaloma (NFAI) are adrenal tumors that have no endocrine function at the time of diagnosis, accounting for roughly 75% of all adrenal incidentaloma ( 5 ). Although most NFAI are benign and non-functional, with no obvious clinical symptoms, it has become an important disease affecting human health, attracting the long-term attention of endocrinologists and urologists due to its relatively high incidence in the population and the potential for malignant lesions ( 3 , 4 , 11 ). Endocrinologists and urologists share the goal of finding an effective, safe, and cost-effective treatment.…”
Section: Discussionmentioning
confidence: 99%
“…Nonfunctional adrenal incidentaloma (NFAI) are adrenal tumors that have no endocrine function at the time of diagnosis, accounting for roughly 75% of all adrenal incidentaloma ( 5 ). Although most NFAI are benign and non-functional, with no obvious clinical symptoms, it has become an important disease affecting human health, attracting the long-term attention of endocrinologists and urologists due to its relatively high incidence in the population and the potential for malignant lesions ( 3 , 4 , 11 ). Endocrinologists and urologists share the goal of finding an effective, safe, and cost-effective treatment.…”
Section: Discussionmentioning
confidence: 99%